RICHMOND, Calif., March 1, 2017 /PRNewswire/ -- Sangamo
Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome
editing, announced today that Sandy
Macrae, M.B., Ch.B., Ph.D., Sangamo's chief executive
officer, will present at the Cowen and Company 37th
Annual Health Care Conference on Wednesday,
March 8th at 9:20 a.m.
Eastern Time. The conference is being held in Boston from March 6-8,
2017.
The presentation will be webcast live and may be accessed via a
link on the Sangamo Therapeutics website in the Investor Relations
section under Events and Presentation. The presentation will be
archived on the Sangamo website for two weeks after the event.
About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating
ground-breaking science into genomic therapies that transform
patients' lives using the company's industry leading platform
technologies in genome editing, gene therapy, gene regulation and
cell therapy. For more information about Sangamo, visit the
Company's website at www.sangamo.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sangamo-therapeutics-announces-presentation-at-the-cowen-and-company-37th-annual-health-care-conference-300416191.html
SOURCE Sangamo Therapeutics, Inc.